» Articles » PMID: 19509173

Cancer DNA Methylation: Molecular Mechanisms and Clinical Implications

Overview
Journal Clin Cancer Res
Specialty Oncology
Date 2009 Jun 11
PMID 19509173
Citations 127
Authors
Affiliations
Soon will be listed here.
Abstract

DNA methylation plays a crucial role in the regulation of gene expression and chromatin organization within normal eukaryotic cells. In cancer, however, global patterns of DNA methylation are altered with global hypomethylation of repeat-rich intergenic regions and hypermethylation of a subset of CpG-dense gene-associated regions (CpG islands). Extensive research has revealed the cellular machinery that catalyzes DNA methylation, as well as several large protein complexes that mediate the transcriptional repression of hypermethylated genes. However, research is only just beginning to uncover the molecular mechanisms underlying the origins of cancer-specific DNA methylation. Herein, we present several recent advances regarding these mechanisms and discuss the relationship between histone modifications (i.e., H3K4me2/3, H4K16Ac, H3K9me2/3, H3K27me3, H4K20me3), chromatin-modifying enzymes (G9a, EZH2, hMOF, SUV4-20H), and aberrant DNA methylation. Additionally, the role played by inflammation, DNA damage, and miRNAs in the etiology of aberrant DNA methylation is considered. Finally, we discuss the clinical implications of aberrant DNA methylation and the utility of methylated biomarkers in cancer diagnosis and management.

Citing Articles

Targeting protein tyrosine phosphatase non-receptor type 6 (PTPN6) as a therapeutic strategy in acute myeloid leukemia.

Wang X, Li Z, Shen J, Liu L Cell Biol Toxicol. 2024; 41(1):11.

PMID: 39707066 PMC: 11662038. DOI: 10.1007/s10565-024-09965-3.


Rockfish: A transformer-based model for accurate 5-methylcytosine prediction from nanopore sequencing.

Stanojevic D, Li Z, Bakic S, Foo R, Sikic M Nat Commun. 2024; 15(1):5580.

PMID: 38961062 PMC: 11222435. DOI: 10.1038/s41467-024-49847-0.


Epigenetic Therapies in Triple-Negative Breast Cancer: Concepts, Visions, and Challenges.

Lehmann U Cancers (Basel). 2024; 16(12).

PMID: 38927870 PMC: 11202282. DOI: 10.3390/cancers16122164.


Current Challenges of Methylation-Based Liquid Biopsies in Cancer Diagnostics.

Rendek T, Pos O, Duranova T, Saade R, Budis J, Repiska V Cancers (Basel). 2024; 16(11).

PMID: 38893121 PMC: 11171112. DOI: 10.3390/cancers16112001.


as a possible novel predictive biomarker of chemotherapy response and death in pediatric B-cell ALL.

Torres-Llanos Y, Zabaleta J, Cruz-Rodriguez N, Quijano S, Guzman P, de Los Reyes I Front Mol Biosci. 2024; 11:1385140.

PMID: 38745909 PMC: 11091394. DOI: 10.3389/fmolb.2024.1385140.


References
1.
Hoque M, Topaloglu O, Begum S, Henrique R, Rosenbaum E, Van Criekinge W . Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects. J Clin Oncol. 2005; 23(27):6569-75. DOI: 10.1200/JCO.2005.07.009. View

2.
Smith J, Mahmood S, Song F, Morrow A, Smiraglia D, Zhang X . Identification of DNA methylation in 3' genomic regions that are associated with upregulation of gene expression in colorectal cancer. Epigenetics. 2007; 2(3):161-72. DOI: 10.4161/epi.2.3.4805. View

3.
Rauch T, Zhong X, Wu X, Wang M, Kernstine K, Wang Z . High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proc Natl Acad Sci U S A. 2007; 105(1):252-7. PMC: 2224196. DOI: 10.1073/pnas.0710735105. View

4.
Belinsky S, Liechty K, Gentry F, Wolf H, Rogers J, Vu K . Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res. 2006; 66(6):3338-44. DOI: 10.1158/0008-5472.CAN-05-3408. View

5.
Satoh A, Toyota M, Itoh F, Sasaki Y, Suzuki H, Ogi K . Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer. Cancer Res. 2003; 63(24):8606-13. View